Rare diseases
Investigational molecules
Locations
Back to Norway12 clinical trials in Gjoevik, Norway. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in NorwayKliniske-Studier.no(opens in a new tab)NorwayNorwayNorwayNorwayNorwayNorwayNorwayNorwayNorwayNorwayNorwayNorwayThe busiest research cities in the country
What the registry says about research in the country
Studies focused on evaluating innovative treatments for inflammatory bowel diseases, including trials assessing combination therapies and long-term effectiveness of medications for ulcerative colitis and Crohn's disease.
Multiple trials are investigating dual-therapy approaches and novel compounds for improved disease control.
Research examining advanced treatments for stroke prevention and management, particularly in patients with atrial fibrillation and those using anticoagulation therapy.
Innovative approaches to thrombolysis and stroke prevention are being evaluated through various clinical protocols.
Comprehensive research into lung cancer treatments, including studies on small-cell and non-small cell lung cancer, investigating combination approaches with immunotherapy and radiotherapy.
Focus on improving survival rates through innovative therapeutic combinations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
